Tuesday - June 09, 2026

Category Archives: Science

Age-related Macular Degeneration Pipeline Appears Robust With 90+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Age-Related Macular Degeneration Pipeline Insight 2026” report provides comprehensive insights about 90+ companies and 100+ pipeline drugs in the Age-Related Macular Degeneration pipeline landscape. It covers the Age-Related Macular Degeneration pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Allied Procurement Converges as Pentagon’s $75 Billion Drone Budget Reshapes the Global UAV Landscape

A structural realignment is underway across the global unmanned systems industry. Defense ministries from Washington to Tokyo are recalibrating procurement around three converging realities: autonomous systems have moved from auxiliary tools to central instruments of modern conflict, allied supply chains … Continue reading →

Lab Grown Diamonds: Whiteflash Precision Lab Focuses on Transparency and Cut Quality

Whiteflash Precision Lab offers premium lab-grown diamonds with outstanding cut quality, brilliance, and value. Discover Whiteflash Precision Lab diamonds, where exceptional cut quality and crystal transparency are physically verified before listing. Shop in-stock lab-grown diamonds backed by advanced light-performance imaging, … Continue reading →

Acute Myeloid Leukemia Pipeline Shows Potential with Active Contributions from 100+ Key Companies | DelveInsight

DelveInsight’s “Acute Myeloid Leukemia Pipeline Insights 2026” report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in Acute Myeloid Leukemia pipeline landscape. It covers the Acute Myeloid Leukemia pipeline drug profiles, including Acute Myeloid Leukemia clinical trials and … Continue reading →

Uveitis Therapeutics Market Size in the 7MM was ~USD 1,468.66 million in 2022 and It is expected to grow at a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Uveitis Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of uveitis, historical and forecasted epidemiology, as well as the uveitis market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the … Continue reading →

Dermatomyositis Clinical Trial Pipeline Gains Momentum: 10+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Dermatomyositis Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Dermatomyositis pipeline landscape. It covers the Dermatomyositis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Dermatomyositis pipeline therapeutics … Continue reading →

Schizophrenia Pipeline Accelerates as 55+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Schizophrenia Pipeline Insight 2026” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in the Schizophrenia pipeline landscape. It covers the Schizophrenia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Schizophrenia Pipeline … Continue reading →

Gorlin Syndrome Clinical Trial Pipeline Accelerates as 5+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Gorlin Syndrome Pipeline Insight, 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Gorlin Syndrome pipeline landscape. It covers the Gorlin Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →